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An outbreak of a rare Shiga-toxin-producing Escherichia coli
serotype (O117:H7) among men who have sex with men
Kate S. Baker,1,* Timothy J. Dallman,2 Nicholas R. Thomson3 and Claire Jenkins2
Abstract
Sexually transmissible enteric infections (STEIs) are commonly associated with transmission among men who have sex with
men (MSM). In the past decade, the UK has experienced multiple parallel STEI emergences in MSM caused by a range of
bacterial species of the genus Shigella, and an outbreak of an uncommon serotype (O117 : H7) of Shiga-toxin-producing
Escherichia coli (STEC). Here, we used microbial genomics on 6 outbreak and 30 sporadic STEC O117 : H7 isolates to explore
the origins and pathogenic drivers of the STEC O117 : H7 emergence in MSM. Using genomic epidemiology, we found that the
STEC O117 : H7 outbreak lineage was potentially imported from Latin America and likely continues to circulate both in the UK
MSM population and in Latin America. We found genomic relationships consistent with existing symptomatic evidence for
chronic infection with this STEC serotype. Comparative genomic analysis indicated the existence of a novel Shiga toxin 1-
encoding prophage in the outbreak isolates, and evidence of horizontal gene exchange among the STEC O117 : H7 outbreak
lineage and other enteric pathogens. There was no evidence of increased virulence in the outbreak strains relative to
contextual isolates, but the outbreak lineage was associated with azithromycin resistance. Comparing these findings with
similar genomic investigations of emerging MSM-associated Shigella in the UK highlighted many parallels, the most striking
of which was the importance of the azithromycin phenotype for STEI emergence in this patient group.
DATA SUMMARY
Three supplementary figures and two supplementary tables
are available with the online version of this article. All sup-
porting data and protocols have been provided within these
supplementary files or the main article.
INTRODUCTION
Certain enteric pathogens traditionally associated with
food-borne or person–person spread can also be transmit-
ted sexually. Outbreaks of such sexually transmissible
enteric infections (STEIs) are frequently associated with
transmission in men who have sex with men (MSM) in
whom oro-anal and genital-anal contact is common. The
wide variety of STEIs includes bacteria of the genera
Shigella, Escherichia, Salmonella and Campylobacter, and
the parasites Giardia lamblia and Entamoeba histolytica [1],
and a number of these have emerged recently in the UK in
parallel with an increase in traditional sexually transmitted
infections (STIs) [2]. Specifically, there has been an intensi-
fication of MSM-associated diarrhoeal disease caused by
diverse bacteria of the genus Shigella since 2009 [3], which
genomic studies have revealed is associated with antimicro-
bial resistance (AMR) [4–6]. In addition to these prolonged
and overlapping shigellosis epidemics, a domestically trans-
mitting outbreak of a Shiga-toxin-producing Escherichia coli
(STEC) O117 : H7 was observed in 2014 in the UK MSM
community [7]. STEC are an important cause of gastroin-
testinal symptoms worldwide, and certain virulence deter-
minants, such as the locus of enterocyte effacement (LEE)
pathogenicity island (PAI) and the Shiga toxin (Stx) subtype
2a are associated with epidemic emergence, and the elabora-
tion of more severe disease syndromes such as haemolytic-
uraemic syndrome [8, 9].
In the UK, STEC O117 : H7 is a rare serotype, often misi-
dentified as Shigella sonnei at local laboratories owing to
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their biochemical similarities and is typically isolated from
patients reporting recent travel abroad [10, 11]. Hence, a
domestically transmitting epidemic of this uncommon sero-
type was unexpected. Full epidemiological and clinical fea-
tures of the STEC O117 : H7 outbreak are reported
elsewhere [7], but briefly, between November 2013 and
August 2014, an outbreak of nine patients occurred. These
patients reported diarrhoeal and other symptoms (e.g.
stomach cramps, fatigue) that were often prolonged (one
patient reported symptoms of 1 month duration prior to
seeking care). Eight of the nine patients were MSM who
contracted their infection in the UK, many of whom had
risk factors in common with those for other STEIs, includ-
ing the UK MSM Shigella epidemics (i.e. human immuno-
deficiency virus infection, high numbers of sexual partners)
[3, 7, 12].
To investigate the emergence of this rare STEC serotype in
MSM, and explore parallels and contrasts with the concur-
rent Shigella epidemics, we performed whole-genome
sequence analysis (WGSA) on six isolates from the 2014
STEC O117 : H7 outbreak, and a further 30 contextual
STEC O117 : H7 isolates collected between 2006 and 2017.
METHODS
Isolates and sequencing by synthesis (Illumina
sequencing)
In total, Illumina sequence data from 36 isolates of STEC
O117 : H7 submitted to, and sequenced by, the Gastrointes-
tinal Bacteria Reference Unit (GBRU) at Public Health Eng-
land (PHE) were examined in this study (Table 1). All
available sequencing data from STEC O117 : H7 isolates
were included in this study. Specifically, this included data
from: isolates sequenced as part of our work published in
2013 [10] (n=5) and other investigations (n=5); isolates
sequenced as part of the outbreak investigation (n=6); and
all O117 : H7 isolated since the implementation of routine
WGSA surveillance at PHE (n=20). Basic patient epidemio-
logical data from sample submission forms (sex, age, history
of recent travel if noted) were also retrieved. Whole-genome
sequencing was performed at PHE using Nextera XT DNA
sample preparation kits and sequencing on an Illumina
HiSeq 2500 instrument [13]. Sequence data quality was
checked using FASTQC (v 0.11.4), and adapter sequences and
5¢ and 3¢ ends (14 and 3 bp, respectively) were trimmed to
remove sequence per base content biases using TRIM GALORE
v. 0.4.5 (CUTADAPT v 1.13). Existing sequencing data was
retrieved from the Short Read Archive, where novel data
was also deposited, under bioproject PRJNA315192 (further
accession numbers are given in Table S1, available with the
online version of this article). Draft genome assemblies were
generated from quality-trimmed data using SPADES v. 3.11.0
[14], improved using a standalone assembly improvement
pipeline [15] based on scaffolding with SSPACE [16] and gap
filling using GapFill [17], and annotated using PROKKA v
1.11 [18].
Single molecule-real time (SM-RT) sequencing of
two outbreak isolates
Complete (but unfinished) genomes were generated for two
outbreak isolates (23168 and 23169, Table S1) through SM-
RT sequencing (as in [6]). Briefly, genomic DNA (200 ng)
was extracted using the MasterPure Complete DNA and
RNA extraction kit, and sequenced on individual SM-RT
cells on a Pacific Biosciences RSII system at the Wellcome
Trust Sanger Institute (Hinxton, UK). Sequencing data were
assembled using HGAP v3 [19], circularized using Circlator v
1.1.3 20] and polished with Quiver v1 (as in [6]).
Phylogenetic analysis
To infer a phylogenetic tree describing the evolutionary
relationships among isolates, trimmed sequencing data were
mapped against the complete genome of isolate 23169 using
SMALT (http://www.sanger.ac.uk/science/tools/smalt-0). For
all isolates after mapping, >90% of the genome was covered,
with repeat mappings discarded (i.e. reads with multiple
best mappings). Overall, between 88 and 95% of reads for
each isolate mapped with a mean depth of 20–90
times coverage (Table S1). Variants were called with Sam-
tools [21] to generate a reference-based multiple sequence
alignment of pseudogenomes. The region of the alignment
relating to the bacterial chromosome (contiguous sequence
OUTCOME
This study investigates, using genomics with contextual
data, the emerging problem of sexually transmissible
enteric infections (STEIs) among men who have sex with
men (MSM). It demonstrates that relatively uncommon
enteric pathogens can emerge as domestically transmit-
ting epidemics in this unique patient group associated
with antimicrobial resistance, in the absence of import-
ant virulence factors. Furthermore, the parallels drawn
between this study and similar studies on other emerg-
ing STEIs in the same MSM community indicates how
microbial genomic studies build on each other to reveal
common drivers of disease processes.
Table 1. Isolates of STEC O117 : H7
Source Years Reference Isolates (n)
Routine WGS surveillance 2014–2017 This paper 20
2014 MSM-outbreak investigation 2013–2014 This paper, epidemiology reported elsewhere [7] 6
Non-routine WGS surveillance 2006–2013 This paper and [10] 10
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1 – see Results) was extracted and recombination removed
using GUBBINS [22]. In total, 3694 non-recombinant variant
sites extracted using SNP-sites [23] among the 36 isolates
were used to infer a maximum-likelihood phylogeny using
RAxML v 8.2.8 [24]. To facilitate discussion and investiga-
tion of the outbreak, the well-supported (bootstrap value of
100) most recent common ancestor of all six epidemiologi-
cally confirmed outbreak isolates was identified and named
the ‘outbreak clade’. Visualizations were made using
iToL [25].
Genomic analysis
To determine the basic architecture of the genome, the iden-
tities of contiguous sequences from the complete genome
assemblies of isolates 23168 and 23169 were compared with
existing sequences and each other. Features common to
both isolates were considered part of the basic genome
architecture. For detection of PAIs, sequences for the LEE-
PAI, locus of adhesion and autoaggregation (LAA) PAI and
the subtilase-encoding PAI (SE-PAI) were downloaded
from the National Center for Biotechnology Information
(NCBI) database, using accession numbers AF022236,
AFDQ01000026.1 (positions 385984–472336) and
JQ9944271, respectively. Genome annotations and PHAST
analysis [26] were used to identify the location of the Stx-
encoding phage. BLAST [27] of the putative Stx-containing
prophage region against the non-redundant NCBI nucleo-
tide database was then used to identify the closest match
(NCBI accession no. NC_028685.1), which was then used in
comparative analysis. Pairwise comparison of phage
sequences was determined using the EMBOSS stretcher modi-
fication of the Needleman–Wunsch algorithm that allows
larger sequences to be globally aligned [28]. For the detec-
tion of virulence and acquired AMR genes, draft and com-
plete genomes were analysed on the ResFinder and
VirulenceFinder web interfaces at the Centre for Genomic
Epidemiology [29, 30], and the amino acids encoded at the
following sites (known to alter fluoroquinolone susceptibil-
ity) were examined in each isolate: gyrA codons 83 and 87;
parC codons 80, 84 and 129. Plasmid visualizations were
made using the BLAST ring image generator [31].
Azithromycin testing
Phenotypic testing of a subset of isolates for reduced suscep-
tibility against azithromycin was performed using the Etest
macromethod (bioMerieux), and statistical comparison of
the frequency of the mphA gene occurrence in outbreak
clade and non-outbreak clade isolates was calculated using a
two-tailed Fisher’s exact test.
RESULTS
Phylogenetic context
To gain epidemiological insight into the outbreak of this
rare STEC serotype, the evolutionary relationships among
the isolates were combined with the patient epidemiological
metadata. This revealed that the six epidemiologically con-
firmed outbreak isolates shared close genetic relationships
with four non-epidemiologically investigated isolates con-
tained within the monophyletic outbreak clade (Fig. 1). Of
the ten outbreak clade isolates, eight were from men and
two were from women. The four non-epidemiologically
confirmed isolates in the outbreak clade comprised two
samples from non-routine WGS surveillance taken in 2010
and 2013 from patients recently returned from Latin Amer-
ica, and two samples isolated much later in 2016 (also from
a recently returned Latin American traveller) and 2017
(submitted in London from a 26-year-old male patient with
no history of travel). Outside of the outbreak clade, there
was also one patient from whom serially collected isolates
were submitted, the first on the 26th of April 2016 after
recent travel to Latin America (SRR4788079), and the sec-
ond on the 8th of August 2016 with no travel history noted
(SRR4787729). These two samples were phylogenetically
adjacent and showed no single nucleotide polymorphisms
(SNPs) between them.
Genome architecture
To characterize the genome features of the strain responsi-
ble for the MSM-associated outbreak, complete genomes
were generated for two outbreak isolates (isolates 23168 and
23169). These assembled into 12 and 15 contiguous sequen-
ces, respectively (Table S2). The two genomes were broadly
syntenic with E. coli O157 : H7 strain Sakai and each other
(Fig. S1). Comparison of the two complete genomes with
the NCBI non-redundant database (Table S2) and each
other revealed a common architecture consisting of a single
bacterial chromosome and three plasmids (Fig. 2). The
smallest plasmid was a ~2 kb cryptic plasmid that had been
detected in unpublished E. coli draft genomes and described
fully as SpC in S. sonnei Ss046 [32]. The second and larger
plasmid shared 100% coverage and 99% nucleotide identity
with p09EL50, a plasmid detected in an STEC O104:H4 iso-
late recovered from a patient with diarrhoea in the Republic
of Georgia in 2009 [33]. Finally, there was a large resistance
plasmid related to (83% coverage, 99% identity) pHU-
SEC41-1, a plasmid recovered from an STEC O104:H4 iso-
late from a patient with haemolytic-uraemic syndrome in
Germany in 2001 [34], and that shared a similar level of
similarity (75% coverage, 99% identity) to a resistance plas-
mid from a MSM-associated sublineage of S. sonnei circulat-
ing in UK MSM (MSMA sublineage 3 in [6]) over a similar
time frame (Fig. 3).
Virulence determinants
To investigate why an STEC serotype that is normally rare
in the UK caused an outbreak, the presence of virulence
determinants was characterized for all isolates (Table S1,
shown in detail for isolate 23168 in Table 2). Further to this,
the complete genome of isolate 23169 was also explored for
the presence of known STEC PAIs and the stx prophage.
This revealed the existence of seven ubiquitous (specifically
capU, gad, iha, sigA, stx1, stx1a, stx1b) virulence determi-
nants and seven non-ubiquitous virulence determinants
among the 36 STEC O117 : H7 isolates (none of which were
enriched in the outbreak clade; Table S1, Fig. S2). Outbreak
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isolate 23 169 did not carry the LEE-PAI or SE-PAI, but did
possess some elements of the recently described modular
LAA-PAI. Specifically, positions 3928350–3935630 of the
23169 genome (contiguous sequence 1) shared 97% identity
with part of module 1, inclusive of genes encoding the
AtoSC two-component system [35], but not the key viru-
lence genes sisA or hes. Similarly, positions 1502495–
1517274 shared 93% identity with part of module 4 of
LAA-PAI, inclusive of ORFs 66–80 (including the known
virulence factor antigen 43 [36]) with the synteny being
interrupted at ORF 69 by the insertion of a transposase
(IS66) in isolate 23169 (Fig. S3). The Stx-encoding prophage
was found in positions 3711427–3799540, with its closest
described relative being a novel stx1a phage Ss-VASD,
recently isolated from S. sonnei taken from human patients
with diarrhoea who had recently travelled to Mexico [37].
However, comparative genomic analysis revealed that the
prophage and Ss-VASD had significant dissimilarity (56%
fragmented coverage with 96% nucleotide identity). In fact,
pairwise alignment of the prophage and phage sequences
resulted in an overall nucleotide identity of 61.6%, suggest-
ing that the prophage is a novel species according to current
guidelines [38]. Accordingly, this T12011virus-like pro-
phage was putatively named ‘Escherichia phage GER2’ and
was deposited separately in GenBank under accession num-
ber MG710528, with annotation information from the
PHAST pipeline.
AMR determinants
The draft genomes of all 36 isolates and complete
genomes of the two SM-RT-sequenced isolates were
examined for genes and mutations known to confer
reduced susceptibility to antimicrobials. The isolates
were found to have numerous genetic determinants of
Fig. 1. The mid-point rooted maximum-likelihood phylogenetic tree shows the evolutionary relationships among 36 STEC O117 : H7
isolates. Epidemiologically determined outbreak isolates are indicated in bold and the monophyletic outbreak clade is shown in red.
The two outbreak isolates that underwent subsequent SM-RT sequencing are indicated by asterisks. The tracks adjacent to the tree
trips show patient gender, travel history, year of isolation (heatmapped) and the presence of azithromycin (AZM)-resistance gene(s)
according to the inlaid key. Missing data in the gender and travel columns are indicated in white.
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resistance against a variety of antimicrobial classes
(Table 2), with all but two isolates containing genes con-
sistent with a multidrug-resistance phenotype (resistance
against 3 antimicrobial classes; Table S1, Fig. S2). Resis-
tance against azithromycin and fluoroquinolones was fur-
ther investigated because of the recent findings of the
importance of these resistance profiles to STEIs in MSM
[39]. Four of the six epidemiologically confirmed out-
break isolates contained the azithromycin-resistance gene
mphA and all four mphA-containing outbreak isolates
were confirmed to have high-level phenotypic resistance
against azithromycin (i.e. MICs of 128–>256mgml 1,
Table S1). The presence of azithromycin-resistance genes
was enriched in the outbreak clade relative to the remain-
der of the tree (5 of 10 isolates, compared with 4 of 26
isolates) though this association fell short of traditional
significance measures (P=0.0794 rather than P<0.05, Fish-
er’s exact test). Although both isolates for which complete
genomes were sequenced contained the mphA gene in
their draft genomes (and had phenotypic azithromycin
resistance confirmed) only one of the two (23168) had
the mphA gene in the complete genome, suggesting it
may have been lost during re-culture. All ten isolates in
the outbreak clade had a mutation in the quinolone-
resistance-determining region of gyrA (S83L), which is
associated with reduced susceptibility against fluoroquino-
lones [40], though this was also common among non-
outbreak clade isolates (Table 3, Fig. S2). Notably, five of
the ten resistance genes in isolate 23168 were carried on
the large pHUSEC41-1-like resistance plasmid (Fig. 3).
DISCUSSION
Combining the evolutionary analysis of outbreak and con-
textual STEC O117 : H7 isolates with traditional epidemio-
logical markers yielded insights into the possible origins,
and potentially ongoing nature of the outbreak. In addition
to the six isolates known to belong to the outbreak, the
encompassing outbreak clade included a further four iso-
lates, three of which were recovered from patients recently
returned from travel to Latin America in 2010, 2013 and
2016. This suggests that the outbreak strain may have origi-
nated in, and continues to circulate in, Latin America.
Though more work is needed to investigate this link, this
mirrors the findings for MSM-associated Shigella flexneri 3a
that emerged in the UK, which was also potentially
imported from Latin America [4]. The fourth non-epidemi-
ologically confirmed isolate in the outbreak clade was from
an adult male whose infection was contracted in the UK
(London) in 2017, suggesting the outbreak strain may still
be circulating in the UK MSM community (though this
Fig. 2. Genome schematic of the STEC O117 : H7 outbreak strain. The bacterial chromosome carries a novel Stx-encoding prophage
and partial modules of the LAA-PAI. Plasmids in the strain include: a small cryptic plasmid (Ss046 SpC), a larger resistance plasmid
(pHUSEC41-1-like R-plasmid) and another larger plasmid (p09EL50).
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speculation is based solely on the patient demographic char-
acteristics, as no epidemiological follow-up of this case was
performed).
The evolutionary analysis also provided genomic evidence
for chronic infection with STEC O117 :H7. Specifically, two
isolates (outside of the outbreak clade) from the same
patient taken 4 months apart were indistinguishable in this
analysis (identical across the 3694 variant sites used for
phylogenetic inference, no virulence or AMR determinant
content differences). This supports the epidemiological
investigation of the outbreak, where symptoms of 1month
were reported [7], and other studies of STEC O117 : H7 that
have also reported repeated isolation for up to 96weeks of
the same serotype in chronically symptomatic persons [11].
Again, this genomic evidence of chronic infection mirrors
observations in S. flexneri 3a among UK MSM where iso-
lates serially isolated from patients 154 days apart were
genetically similar (0–4 SNPs) [4]. Although clinical investi-
gations are urgently needed to accurately determine the
duration of infection and clinical presentation (e.g. asymp-
tomatic, intermittently symptomatic, chronically symptom-
atic) of STEIs in MSM, these findings indicate that multiple
STEIs are capable of chronic (4months duration)
infection.
Analysis of the accessory genome of the outbreak isolate
indicated likely horizontal gene flow between pathogenic
E. coli and shigellae. This was supported by the presence of
plasmid p09EL50 in the outbreak isolate; a plasmid origin-
ally described in a 2009 STEC O104 : H4 strain from the
Republic of Georgia [33]. Similarly, the pHUSEC41-like
large resistance plasmid in the outbreak strain was most
closely related with a plasmid isolated from a sublineage of
S. sonnei (MSM-associated sublineage 3) that was circulat-
ing in UK MSM over a similar timeframe to the 2014 STEC
outbreak, providing a plausible opportunity for direct or
indirect genetic exchange between these two pathogen sub-
types. The finding of shared AMR determinants among dis-
tinct STEIs in the MSM community complements results
from a recent WGSA study of overlapping Shigella epidem-
ics in UK MSM where a resistance plasmid, pKSR100, was
shared among five co-circulating polyphyletic Shigella
Fig. 3. Plasmid comparative genomics. The pHUSEC41-1-like plasmid
from the MSM-associated STEC O117 : H7 outbreak strain (isolate
23168) is shown centrally, with AMR genes on the plasmid annotated
as red arrows in the adjacent ring. Regions of plasmid similarity (70–
100% with BLAST) to MSM-associated S. sonnei sublineage 3 plasmid
(isolate ERS1017839) [6] and pHUSEC41-1 from STEC O104:H4 (NCBI
accession no. HE603110.1) are shown in grey in the outer rings
according to the inlaid key. Additional AMR genes carried on the MSM-
associated S. sonnei sublineage 3 plasmid are shown in blue. AMR
gene names are shown outermost.
Table 2. Virulence determinants and locations found in isolate 23168
Virulence factor Contiguous sequence Position Protein function Accession no.
capU ERS1746629|SC|contig000001 1543785–1544873 Hexosyltransferase homologue CP003034
gad ERS1746629|SC|contig000001 2456206–2457606 Glutamate decarboxylase CP001671
iha ERS1746629|SC|contig000001 3055028–3057118 Adherence protein AE005174
sigA ERS1746629|SC|contig000001 3077450–3081307 Shigella IgA-like protease homologue CP000038
stx1a ERS1746629|SC|contig000001 3751577–3752525 Shiga toxin 1, subunit A, variant a EF079675
stx1b ERS1746629|SC|contig000001 3752535–3752804 Shiga toxin 1, subunit B, variant a AM230663
gad ERS1746629|SC|contig000001 4771849–4773249 Glutamate decarboxylase CP001671
stx1 ERS1746629|SC|contig000001 3751577–3752804 Shigella dysenteriae 3818T M19437
astA ERS1746629|SC|contig000003 22 974–23090 EAST-1 heat-stable toxin AB042002
cba ERS1746629|SC|contig000003 2916–3854 Colicin B FJ664721
senB ERS1746629|SC|contig000003 31 963–33138 Plasmid-encoded enterotoxin CP000038
cba ERS1746629|SC|contig000003 9589–10527 Colicin B FJ664721
celb ERS1746629|SC|contig000012 5441–5584 Endonuclease colicin E2 AF540491
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sublineages (three of S. sonnei, one of S. flexneri 2a and one
S. flexneri 3a) [5, 6].
To explore a possible pathogenic basis for the emergence of
this rare STEC serotype in MSM, outbreak isolates were inves-
tigated for the presence of virulence determinants. Virulence
determinants associated with more severe disease presenta-
tions, including Stx2a and the LEE-PAI, were not present in
the outbreak clade. Increasing evidence suggests that LEE-neg-
ative STEC may have common virulence determinants that
contribute to their clinical presentation such as the SE- and
LAA-PAIs [41, 42]. Although partial modules of the recently
described LAA-PAI were present, the regions of similarity did
not contain many of the key virulence determinants, and the
SE-PAI was absent. The outbreak clade did contain the Shiga-
toxin-encoding genes stx1a and stx1b on a novel prophage
most closely related with an stx1a phage isolated from S. son-
nei from human patients in Mexico [37], and also contained
the virulence factor sigA. However, these key virulence deter-
minants typically associated with Shigella (i.e. stx1a, stx1b and
sigA) were also ubiquitous among the contextual isolates. To
summarize then, virulence determinants were not markedly
different between outbreak and contextual isolates, so were
not likely to have contributed to the aberrant emergence of
this rare serotype in MSM.
Outbreak and contextual isolates were distinguishable, how-
ever, through the enrichment of genes encoding azithromycin
resistance among isolates in the outbreak clade, highlighting
the increasingly apparent role of AMR in epidemics of STEIs
in MSM. The three subtypes of Shigella causing outbreaks
among UK MSM were also associated with azithromycin
resistance relative to the contextual isolates in those studies [4,
6]. This common association of azithromycin resistance
among four different STEIs in UK MSM confirms the impor-
tance of this resistance phenotype in driving STEI emergence
in this patient group. Although no specific studies have evalu-
ated relative antimicrobial usage patterns between STEI-
affected MSM and other patient groups, treatment reviews
have shown that antimicrobial use is frequent in STEI-affected
MSM [43, 44] and that many patients have recent or co-mor-
bid infection with other bacterial STIs, many of which are
treated with azithromycin [4, 12]. These two features com-
bined would plausibly create sustained selective pressure for
azithromycin resistance, particularly for pathogens where the
infection window is chronic. And, the chronic infection
window also facilitates ample opportunity for horizontal
genetic exchange between STEI pathogens in MSM, either
directly or indirectly via the microbiota, which may act as a
reservoir for AMR in these patients.
These results have implications for public health practice.
Outbreaks of enteric illnesses are not typically investigated
for association with sexual activity in MSM (though this is
changing in the UK consequent to the recent epidemics).
The continued finding of STEI emergence associated with
azithromycin resistance indicates that it may be useful to
investigate and manage azithromycin-resistant enteric ill-
ness outbreaks as being potentially associated with sexual
transmission. Furthermore, the tendency of STEIs in MSM
to be resistant to azithromycin, which is not necessarily the
primary treatment for enteric illness, suggests that treat-
ment for other illnesses, including non-enteric bacterial
STIs, may be creating a sustained selection pressure for
resistance in other pathogens. This selection pressure can
then drive pathogen evolution through horizontal gene
transfer and potentially cause unexpected changes in epide-
miology, such as the emergence of a rare serotype. To work
toward a public-health framework where such rapid
changes in epidemiology are de-mystified, we must continue
to scrutinize pathogens at the genomic level, characterize
gene flow among different bacterial populations, and inte-
grate this information with detailed epidemiological data.
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